The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression and mortality post-immunotherapy discontinuation among patients with BRAFV600-mutant (BRAF+) metastatic melanoma.
 
Sunandana Chandra
Honoraria - Array BioPharma; Bristol Myers Squibb; EMD Serono; Exicure; Novartis; Pfizer; Sanofi/Regeneron
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Exicure; Novartis; Pfizer; Sanofi/Regeneron
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); exicure (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst)
 
Evan Thomas Hall
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); Treatment Technologies and Insights (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Cancer Support Community
 
You-Li Ling
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jackson Tang
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.
 
Rohan Shah
Employment - Novartis
 
Thach-Giao Truong
No Relationships to Disclose